Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Clinical trial NCT00551330 · COMPLETED

Trial details

NCT number: NCT00551330
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Acquired Immunodeficiency Syndrome

Start date: 2007-09-01
Primary completion: 2010-02-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.